Physician profile
Michael Thomas Scott
NPI 1801277595
$890.52
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $389 · 2023: $90.18 · 2024: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $424.84 | 2021-2022 | |
| Edwards Lifesciences Corporation | $94.36 | 2021 | |
| Thd America, INC. | $86.67 | 2024 | |
| Abbvie INC. | $69.30 | 2023 | Skyrizi |
| Braintree Laboratories, INC. | $57.97 | 2024 | Suflave |
| Ethicon US, LLC | $31.28 | 2024 | Echelon Circular |
| Pfizer INC. | $25.88 | 2024 | |
| Hologic Sales and Service, LLC | $22.98 | 2024 | Coolseal Generator |
| Pacira Pharmaceuticals Incorporated | $20.30 | 2024 | Exparel |
| Astrazeneca Pharmaceuticals Lp | $19.40 | 2024 | Enhertu |
| Olympus America INC. | $16.66 | 2024 | Evis Exera III Colonovideoscope, Olympus |
| Takeda Pharmaceuticals U.S.A., INC. | $14.87 | 2023 | Gattex |
| Intuitive Surgical, INC. | $6.01 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.